(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Canaan, Globalstar, and Huntington Bancshares.

Rank	Financial Asset	Price	Premarket Change	Updated (EST)
1	Canaan (CAN)	2.93	3.17%	2023-07-13 07:13:53
2	Globalstar (GSAT)	1.08	1.89%	2023-07-13 04:47:23
3	Huntington Bancshares (HBAN)	11.34	1.7%	2023-07-13 07:10:20
4	Bionano Genomics (BNGO)	0.66	1.68%	2023-07-13 07:13:48
5	Plug Power (PLUG)	11.64	1.22%	2023-07-13 07:11:52
6	Koninklijke Philips (PHG)	22.72	1.2%	2023-07-13 04:44:07
7	Tilray (TLRY)	1.74	1.16%	2023-07-13 07:15:31
8	Banco Bilbao Vizcaya Argentaria (BBVA)	7.97	1.01%	2023-07-13 07:16:49
9	Pacific Biosciences of California (PACB)	13.95	1.01%	2023-07-13 07:11:47
10	Canopy Growth (CGC)	0.57	0.98%	2023-07-13 07:21:43

The three biggest losers today are iRobot, Niu Technologies, and Fox Corporation.

Rank	Financial Asset	Price	Premarket Change	Updated (EST)
1	iRobot (IRBT)	46.07	-1.98%	2023-07-13 07:10:46
2	Niu Technologies (NIU)	4.35	-1.14%	2023-07-13 07:14:48
3	Fox Corporation (FOX)	31.35	-0.85%	2023-07-13 04:09:50
4	Upland Software (UPLD)	4.32	-0.69%	2023-07-13 04:12:47
5	Inovio Pharmaceuticals (INO)	0.53	-0.11%	2023-07-13 07:10:37
6	Boston Scientific (BSX)	52.44	-0.04%	2023-07-13 04:38:48
7	Pembina Pipeline (PBA)	31.00	-0.03%	2023-07-13 04:43:48
8	Sun Life Financial (SLF)	50.81	-0.01%	2023-07-13 04:20:20
9	CMS Energy (CMS)	60.82	0%	2023-07-13 04:39:22
10	iShares J.P. Morgan (EMB)	86.51	0%	2023-07-13 04:13:56

Premarket Winners today

1. Canaan (CAN) – Premarket: 3.17%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan dropping 2.91% to $2.84 on Thursday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.57.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.4%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canaan’s EBITDA is -2.02.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be oversold (<=20).

More news about Canaan.

2. Globalstar (GSAT) – Premarket: 1.89%

Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications. It also provides one-way or two-way communications and data transmissions using mobile devices, including the SPOT family of products, such as SPOT X, SPOT Gen4, and SPOT Trace that transmit messages and the location of the device; commercial Internet of Things transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets; small satellite transmitter modules, such as the STX-3, ST-150 and ST100, and chips that enable an integrator's products to access company's network; and engineering and other communication services using MSS and terrestrial spectrum licenses, as well as undertakes installation of gateways and antennas. The company distributes its products through retailers, sales force, and e-commerce website. Globalstar, Inc. serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. The company was founded in 1993 and is headquartered in Covington, Louisiana.

NYSE ended the session with Globalstar jumping 0.48% to $1.06 on Thursday while NYSE jumped 0.72% to $16,011.28.

Earnings Per Share

As for profitability, Globalstar has a trailing twelve months EPS of $-0.13.

Sales Growth

Globalstar’s sales growth is 39.7% for the current quarter and 41% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be oversold (<=20).

Volatility

Globalstar’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.96%, a negative 0.88%, and a positive 3.41%.

Globalstar’s highest amplitude of average volatility was 1.91% (last week), 3.27% (last month), and 3.41% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 100% and 100%, respectively.

More news about Globalstar.

3. Huntington Bancshares (HBAN) – Premarket: 1.7%

Huntington Bancshares Incorporated operates as the bank holding company for The Huntington National Bank that provides commercial, consumer, and mortgage banking services in the United States. The company operates through four segments: Consumer and Business Banking; Commercial Banking; Vehicle Finance; and Regional Banking and The Huntington Private Client Group (RBHPCG). The Consumer and Business Banking segment offers financial products and services, such as checking accounts, savings accounts, money market accounts, certificates of deposit, credit cards, and consumer and small business loans, as well as investment products. This segment also provides mortgages, insurance, interest rate risk protection, foreign exchange, automated teller machine, and treasury management services, as well as online, mobile, and telephone banking services. It serves consumer and small business customers. The Commercial Banking segment offers regional commercial banking solutions for middle market businesses, government and public sector entities, and commercial real estate developers/REITs; and specialty banking solutions for healthcare, technology and telecommunications, franchise finance, sponsor finance, and global services industries. It also provides asset finance services; capital raising solutions, sales and trading, and corporate risk management products; institutional banking services; and treasury management services. The Vehicle Finance segment provides financing to consumers for the purchase of automobiles, light-duty trucks, recreational vehicles, and marine craft at franchised and other select dealerships, as well as to franchised dealerships for the acquisition of new and used inventory. The RBHPCG segment offers private banking, wealth and investment management, and retirement plan services. Huntington Bancshares Incorporated was founded in 1866 and is headquartered in Columbus, Ohio.

NASDAQ ended the session with Huntington Bancshares rising 1.04% to $11.15 on Thursday, after two consecutive sessions in a row of gains. NASDAQ rose 1.15% to $13,918.96, after three sequential sessions in a row of gains, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Huntington Bancshares has a trailing twelve months EPS of $1.52.

PE Ratio

Huntington Bancshares has a trailing twelve months price to earnings ratio of 7.33. Meaning, the purchaser of the share is investing $7.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.83%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 7.17B for the twelve trailing months.

Yearly Top and Bottom Value

Huntington Bancshares’s stock is valued at $11.15 at 08:34 EST, way under its 52-week high of $15.74 and way higher than its 52-week low of $9.13.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Huntington Bancshares’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 2.9% and a negative 15.4%, respectively.

More news about Huntington Bancshares.

4. Bionano Genomics (BNGO) – Premarket: 1.68%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics jumping 1.34% to $0.65 on Thursday, after three successive sessions in a row of gains. NASDAQ jumped 1.15% to $13,918.96, after three consecutive sessions in a row of gains, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.51%.

More news about Bionano Genomics.

5. Plug Power (PLUG) – Premarket: 1.22%

Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.

NASDAQ ended the session with Plug Power jumping 2.86% to $11.50 on Thursday while NASDAQ rose 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Plug Power has a trailing twelve months EPS of $-1.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.43%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Plug Power’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Plug Power is 27261000 which is 12.13% above its average volume of 24310800.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Plug Power’s EBITDA is -31.24.

Previous days news about Plug Power

• : Plug Power stock advances after company wins an electrolyzer deal in Australia. According to MarketWatch on Wednesday, 12 July, "Shares of Plug Power Inc. were gaining about 3% in Wednesday morning trading after the alternative-energy company announced that it was chosen to supply two 5-megawatt proton exchange membrane (PEM) electrolyzers for projects in Australia. ", "The plants are strategically located to leverage existing infrastructure," Plug Power Chief Executive Andy Marsh said in a release. "
• : Plug Power stock advances after company wins an electrolyzer deal in Australia. According to MarketWatch on Wednesday, 12 July, "Shares of Plug Power Inc. were gaining about 3% in Wednesday morning trading after the alternative-energy company announced that it was chosen to supply two 5-megawatt proton exchange membrane (PEM) electrolyzers for projects in Australia. ", "The plants are strategically located to leverage existing infrastructure," Plug Power Chief Executive Andy Marsh said in a release. "

More news about Plug Power.

6. Koninklijke Philips (PHG) – Premarket: 1.2%

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

NYSE ended the session with Koninklijke Philips rising 2.96% to $22.45 on Thursday, after five sequential sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after four consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Koninklijke Philips has a trailing twelve months EPS of $-2.62.

Yearly Top and Bottom Value

Koninklijke Philips’s stock is valued at $22.45 at 08:34 EST, higher than its 52-week high of $22.34.

Volume

Today’s last reported volume for Koninklijke Philips is 882682 which is 15.09% below its average volume of 1039620.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Koninklijke Philips’s EBITDA is -39.15.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Koninklijke Philips’s stock is considered to be oversold (<=20).

More news about Koninklijke Philips.

7. Tilray (TLRY) – Premarket: 1.16%

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

NASDAQ ended the session with Tilray sliding 2.82% to $1.72 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.15% to $13,918.96, after three consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-3.31.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 94.4% and 61.5%, respectively.

More news about Tilray.

8. Banco Bilbao Vizcaya Argentaria (BBVA) – Premarket: 1.01%

Banco Bilbao Vizcaya Argentaria, S.A., together with its subsidiaries, provides retail banking, wholesale banking, and asset management services. It offers current accounts; and demand, savings, overnight, time, term, and subordinated deposits. The company also provides loan products; deals in securities; leasing, factoring, brokerage, and asset management services; and manages pension and investment funds. In addition, it offers credit cards; corporate and investment banking services; insurance products and services; and real estate services. The company provides its products through online and mobile channels. It operates in Spain, Mexico, South America, the United States, Turkey, Asia, and rest of Europe. Banco Bilbao Vizcaya Argentaria, S.A. was founded in 1857 and is headquartered in Bilbao, Spain.

NYSE ended the session with Banco Bilbao Vizcaya Argentaria jumping 2.8% to $7.89 on Thursday, after two consecutive sessions in a row of gains. NYSE rose 0.72% to $16,011.28, after four consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Banco Bilbao Vizcaya Argentaria has a trailing twelve months EPS of $1.18.

PE Ratio

Banco Bilbao Vizcaya Argentaria has a trailing twelve months price to earnings ratio of 6.69. Meaning, the purchaser of the share is investing $6.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Bilbao Vizcaya Argentaria’s stock is considered to be oversold (<=20).

Volatility

Banco Bilbao Vizcaya Argentaria’s last week, last month’s, and last quarter’s current intraday variation average was 1.54%, 0.66%, and 1.68%.

Banco Bilbao Vizcaya Argentaria’s highest amplitude of average volatility was 1.59% (last week), 1.46% (last month), and 1.68% (last quarter).

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 2, 2023, the estimated forward annual dividend rate is 0.46 and the estimated forward annual dividend yield is 6.21%.

More news about Banco Bilbao Vizcaya Argentaria.

9. Pacific Biosciences of California (PACB) – Premarket: 1.01%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California jumping 1.92% to $13.81 on Thursday, after four sequential sessions in a row of gains. NASDAQ rose 1.15% to $13,918.96, after three consecutive sessions in a row of gains, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.97%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.3%, now sitting on 134.03M for the twelve trailing months.

Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $13.81 at 08:34 EST, under its 52-week high of $14.30 and way higher than its 52-week low of $3.89.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.27%, a negative 0.09%, and a positive 2.38%.

Pacific Biosciences of California’s highest amplitude of average volatility was 3.27% (last week), 2.87% (last month), and 2.38% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pacific Biosciences of California’s stock is considered to be oversold (<=20).

More news about Pacific Biosciences of California.

10. Canopy Growth (CGC) – Premarket: 0.98%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth jumping 1.63% to $0.56 on Thursday, after five consecutive sessions in a row of gains. NASDAQ jumped 1.15% to $13,918.96, after three successive sessions in a row of gains, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-6.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.

Moving Average

Canopy Growth’s worth is way under its 50-day moving average of $0.93 and way below its 200-day moving average of $2.23.

Revenue Growth

Year-on-year quarterly revenue growth declined by 27.6%, now sitting on 402.9M for the twelve trailing months.

Volatility

Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was a positive 9.27%, a negative 1.09%, and a positive 5.85%.

Canopy Growth’s highest amplitude of average volatility was 9.27% (last week), 10.14% (last month), and 5.85% (last quarter).

Yearly Top and Bottom Value

Canopy Growth’s stock is valued at $0.56 at 08:34 EST, way below its 52-week high of $4.77 and way higher than its 52-week low of $0.38.

More news about Canopy Growth.

Premarket Losers Today

1. iRobot (IRBT) – Premarket: -1.98%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot jumping 0.56% to $47.00 on Thursday, after two sequential sessions in a row of gains. NASDAQ jumped 1.15% to $13,918.96, after three successive sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-12.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.8%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, iRobot’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

iRobot’s stock is valued at $47.00 at 08:34 EST, way under its 52-week high of $60.25 and way higher than its 52-week low of $31.37.

Moving Average

iRobot’s worth is way above its 50-day moving average of $39.62 and above its 200-day moving average of $46.25.

More news about iRobot.

2. Niu Technologies (NIU) – Premarket: -1.14%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies jumping 2.45% to $4.40 on Thursday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.41%.

More news about Niu Technologies.

3. Fox Corporation (FOX) – Premarket: -0.85%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation dropping 0.25% to $31.62 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.15% to $13,918.96, after three consecutive sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.14.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 14.78. Meaning, the purchaser of the share is investing $14.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

More news about Fox Corporation.

4. Upland Software (UPLD) – Premarket: -0.69%

Upland Software, Inc. provides cloud-based enterprise work management software in the United States, the United Kingdom, Canada, and internationally. It offers a family of software applications under the Upland brand in the areas of marketing, sales, contact center, project management, information technology, business operations, and human resources and legal. The company also provides professional services, such as implementation, data extraction, integration and configuration, and training services, as well as customer support services. It serves large global corporations, various government agencies, and small and medium-sized businesses, as well as financial, consulting, technology, manufacturing, media, telecommunication, political, healthcare, life sciences, and retail and hospitality sectors. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. Upland Software, Inc. was incorporated in 2010 and is headquartered in Austin, Texas.

NASDAQ ended the session with Upland Software falling 3.01% to $4.35 on Thursday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Upland Software has a trailing twelve months EPS of $-6.07.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -60.96%.

Moving Average

Upland Software’s worth is way above its 50-day moving average of $3.36 and way under its 200-day moving average of $6.29.

Volatility

Upland Software’s last week, last month’s, and last quarter’s current intraday variation average was 2.71%, 0.97%, and 3.63%.

Upland Software’s highest amplitude of average volatility was 4.21% (last week), 3.72% (last month), and 3.63% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 315.64M for the twelve trailing months.

More news about Upland Software.

5. Inovio Pharmaceuticals (INO) – Premarket: -0.11%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals sliding 1.69% to $0.53 on Thursday, following the last session’s downward trend. NASDAQ rose 1.15% to $13,918.96, after three sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.97.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

More news about Inovio Pharmaceuticals.

6. Boston Scientific (BSX) – Premarket: -0.04%

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

NYSE ended the session with Boston Scientific jumping 0.02% to $52.46 on Thursday, following the last session’s upward trend. NYSE rose 0.72% to $16,011.28, after four sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Boston Scientific has a trailing twelve months EPS of $0.59.

PE Ratio

Boston Scientific has a trailing twelve months price to earnings ratio of 88.92. Meaning, the purchaser of the share is investing $88.92 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.18%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12%, now sitting on 13.05B for the twelve trailing months.

Volatility

Boston Scientific’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.01%, a positive 0.17%, and a positive 0.83%.

Boston Scientific’s highest amplitude of average volatility was 0.64% (last week), 0.87% (last month), and 0.83% (last quarter).

Volume

Today’s last reported volume for Boston Scientific is 2920470 which is 66.64% below its average volume of 8754740.

More news about Boston Scientific.

7. Pembina Pipeline (PBA) – Premarket: -0.03%

Pembina Pipeline Corporation provides energy transportation and midstream services. It operates through three segments: Pipelines, Facilities, and Marketing & New Ventures. The Pipelines segment operates conventional, oil sands and heavy oil, and transmission assets with a transportation capacity of 2.8 millions of barrels of oil equivalent per day, the ground storage capacity of 11 millions of barrels, and rail terminalling capacity of approximately 105 thousands of barrels of oil equivalent per day serving markets and basins across North America. The Facilities segment offers infrastructure that provides customers with natural gas, condensate, and natural gas liquids (NGLs), including ethane, propane, butane, and condensate; and includes 354 thousands of barrels per day of NGL fractionation capacity, 21 millions of barrels of cavern storage capacity, and associated pipeline and rail terminalling facilities. The Marketing & New Ventures segment buys and sells hydrocarbon liquids and natural gas originating in the Western Canadian sedimentary basin and other basins. Pembina Pipeline Corporation was founded in 1954 and is headquartered in Calgary, Canada.

NYSE ended the session with Pembina Pipeline rising 1.84% to $31.01 on Thursday while NYSE jumped 0.72% to $16,011.28.

Earnings Per Share

As for profitability, Pembina Pipeline has a trailing twelve months EPS of $3.7.

PE Ratio

Pembina Pipeline has a trailing twelve months price to earnings ratio of 8.38. Meaning, the purchaser of the share is investing $8.38 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.9%.

More news about Pembina Pipeline.

8. Sun Life Financial (SLF) – Premarket: -0.01%

Sun Life Financial Inc., a financial services company, provides savings, retirement, and pension products worldwide. It offers term and permanent life, as well as personal health, dental, critical illness, long-term care, and disability insurance products. The company provides financial advice, asset management, and investments related products. It is also involved in mutual fund and investment management businesses. Sun Life Financial Inc was founded in 1871 and is headquartered in Toronto, Canada.

NYSE ended the session with Sun Life Financial rising 0.65% to $50.81 on Thursday, after two successive sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after four successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Sun Life Financial has a trailing twelve months EPS of $4.1.

PE Ratio

Sun Life Financial has a trailing twelve months price to earnings ratio of 12.39. Meaning, the purchaser of the share is investing $12.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.23%.

Moving Average

Sun Life Financial’s worth is higher than its 50-day moving average of $49.50 and above its 200-day moving average of $46.81.

Sales Growth

Sun Life Financial’s sales growth is negative 89.1% for the ongoing quarter and negative 89.6% for the next.

More news about Sun Life Financial.

9. CMS Energy (CMS) – Premarket: 0%

CMS Energy Corporation operates as an energy company primarily in Michigan. The company operates through three segments: Electric Utility; Gas Utility; and Enterprises. The Electric Utility segment is involved in the generation, purchase, transmission, distribution, and sale of electricity. This segment generates electricity through coal, wind, gas, renewable energy, oil, and nuclear sources. Its distribution system comprises 208 miles of high-voltage distribution overhead lines; 4 miles of high-voltage distribution underground lines; 4,428 miles of high-voltage distribution overhead lines; 19 miles of high-voltage distribution underground lines; 82,474 miles of electric distribution overhead lines; 9,395 miles of underground distribution lines; 1,093 substations; and 3 battery facilities. The Gas Utility segment engages in the purchase, transmission, storage, distribution, and sale of natural gas, which includes 2,392 miles of transmission lines; 15 gas storage fields; 28,065 miles of distribution mains; and 8 compressor stations. The Enterprises segment is involved in the independent power production and marketing, including the development and operation of renewable generation. It serves 1.9 million electric and 1.8 million gas customers, including residential, commercial, and diversified industrial customers. The company was incorporated in 1987 and is headquartered in Jackson, Michigan.

NYSE ended the session with CMS Energy rising 1.85% to $60.82 on Thursday while NYSE jumped 0.72% to $16,011.28.

Earnings Per Share

As for profitability, CMS Energy has a trailing twelve months EPS of $2.3.

PE Ratio

CMS Energy has a trailing twelve months price to earnings ratio of 26.44. Meaning, the purchaser of the share is investing $26.44 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.79%.

Moving Average

CMS Energy’s worth is higher than its 50-day moving average of $59.88 and higher than its 200-day moving average of $60.42.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CMS Energy’s stock is considered to be oversold (<=20).

More news about CMS Energy.

10. iShares J.P. Morgan (EMB) – Premarket: 0%

NASDAQ ended the session with iShares J.P. Morgan jumping 1.19% to $86.51 on Thursday while NASDAQ rose 1.15% to $13,918.96.

Earnings Per Share

As for profitability, iShares J.P. Morgan has a trailing twelve months EPS of $4.9.

Volatility

iShares J.P. Morgan’s last week, last month’s, and last quarter’s current intraday variation average was 0.54%, 0.06%, and 0.38%.

iShares J.P. Morgan’s highest amplitude of average volatility was 0.60% (last week), 0.47% (last month), and 0.38% (last quarter).

More news about iShares J.P. Morgan.

Stay up to date with our premarket winners and losers daily report